Arcturus Therapeutics Holdings Inc stock is traded at $9.31, with a volume of 86,470. It is down -0.85% in the last 24 hours and down -32.24% over the past month. Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Previous Close:
$9.39
Open:
$9.41
24h Volume:
86,470
Relative Volume:
0.11
Market Cap:
$268.34M
Revenue:
$42.35M
Net Income/Loss:
-$78.67M
P/E Ratio:
-
EPS:
-$2.82
Net Cash Flow:
-$63.18M
1W Performance:
-14.35%
1M Performance:
-32.24%
6M Performance:
+7.82%
1Y Performance:
+7.38%
1-Day Range:
$9.28$9.67
1-Week Range:
$9.15$10.80
52-Week Range:
$5.50$17.96
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
Name
Arcturus Therapeutics Holdings IncSector
HealthcareIndustry
BiotechnologyPhone
(858) 900-2660Address
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS